MDAI

Spectral AI, Inc. (NASDAQ:MDAI) is a Dallas-based artificial intelligence company founded to revolutionize medical diagnostics in wound care. The company went public in April 2021 and has since focused on developing AI-powered diagnostic tools that help healthcare providers make faster and more accurate treatment decisions for patients with burns and diabetic foot ulcers. Spectral AI's flagship product, the DeepView system, represents a significant advancement in wound assessment technology, offering objective analysis capabilities that often surpass traditional clinical judgment.